Previous close | 16.80 |
Open | 16.80 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 70.00 |
Expiry date | 2025-06-20 |
Day's range | 16.80 - 16.80 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Invaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, today announced the appointment of André Andonian as the new Chairman of its Board of Directors. Robert Berendes has decided to step down after serving as Chairman of the Board since 2019 and will continue to serve on the board of Invaio.
Moderna stock tumbled after the company issued a light 2025 sales outlook and cut its 2027 R&D budget. Is MRNA stock a sell?
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared with treatment with Comirnaty.